The sportswear market has become increasingly flooded with high-end “super shoes” for running, often constructed from lightweight materials and containing
These Triathletes Tested a \u2018Super Shoe\u2019 Against a Cheaper Running Shoe
AI platform finds best combination of available therapies against COVID-19
A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to
Reduced traffic from the world’s busiest airports is a tool against future waves of COVID-19
COVID-19 can be fought with interventions aimed at reducing community transmission and international travel by 80% for eight weeks, according
Microbes in the gut could be protective against hazardous radiation exposure
A new study by scientists at UNC Lineberger Comprehensive Cancer Center and colleagues published Oct. 30, 2020, in Science, showed
Dr. Marc Siegel: 'I'm so happy' to see WHO warning against coronavirus lockdowns
World Health Organization changes its tune about COVID lockdowns Fox News medical contributor Dr. Marc Siegel gives his reaction on
An Upside to the Common Cold? It May Guard Against COVID
MONDAY, Oct. 5, 2020 — The common cold can make you miserable, but it might also help protect you against
Antibody study suggests more lasting immunity against COVID than believed
(HealthDay)—In a finding that should encourage scientists who are racing to develop coronavirus vaccines, a new study out of Iceland
Another mRNA-based vaccine candidate protects animals against SARS-CoV-2
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice
Two immunotherapies merged into single, more effective treatment that may work against variety of cancers
Some of the most promising advances in cancer treatment have centered on immunotherapies that rev up a patient’s immune system
Monoclonal antibody against COVID-19 enters clinical trial
On June 5, 2020, China’s National Medical Products Administration (NMPA) officially approved the clinical trials for a fully human monoclonal